Table 2.
Predictors of occurrence of relapse in the first year of treatment
| |
Univariate analysis |
Multivariate analysis |
||||
|---|---|---|---|---|---|---|
| OR | CI | P | OR | CI | P | |
| Sex (female vs male) |
2.31 |
0.57–9.32 |
0.24 |
- |
- |
- |
| Age |
1.00 |
0.94–1.07 |
0.88 |
- |
- |
- |
| Disease duration |
1.01 |
0.92–1.11 |
0.81 |
- |
- |
- |
| ARR in the pre-treatment year |
0.98 |
0.63–1.54 |
0.93 |
- |
- |
- |
| EDSS gain the pre-treatment year |
1.53 |
0.89–2.62 |
0.12 |
- |
- |
- |
| EDSS at baseline |
1.25 |
0.90–1.75 |
0.18 |
- |
- |
- |
|
EDSS at baseline, categorized |
|
|
0.62 |
- |
- |
- |
| 3.0 to 3.5 compared to < = 2.5 |
0.08 |
0.18–6.44 |
0.93 |
- |
- |
- |
| 4.0 to 5.5 compared to < = 2.5 |
1.58 |
0.29–8.61 |
0.6 |
- |
- |
- |
| 6 and above compared to < = 2.5 |
2.60 |
0.52–13.04 |
0.24 |
- |
- |
- |
| High pre-treatment disease activity | 4.12 | 1.05–16.23 | 0.04 | 4.12 | 1.05–16.23 | 0.04 |
OR: odds ratio. CI = 95% Confidence Interval.
Univariate and multivariate logistic regression analysis.